U.S. Biopharmaceutical company, AntriaBio establishes branch in Seoul

Published: 2016-09-26 13:26:28

Updated: 2016-09-26 13:26:28

A biopharmaceutical company located in U.S. Colorado, which is developing a new extended release type of treatment, AntriaBio Inc. announced it will found an affiliate in Seoul and seek for plans to conduct R&Ds and manufacture pharmaceutical products.

AntriaBio is planning to complete fund-raising to found the company by the end of the year mostly from Korean investing institutions. The raise...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.